Authors: LIZARDNACOL S COUDERT B RIEDINGER JM FARGEOT P GUERRIN J

Citation: S. Lizardnacol et al., P53 GENE ALTERATIONS ARE ASSOCIATED WITH A DECREASED RESPONSIVENESS TO NEOADJUVANT CHEMOTHERAPY IN HUMAN BREAST-CANCER, International journal of oncology, 10(6), 1997, pp. 1203-1207

Authors: LIZARDNACOL S RIEDINGER JM LIZARD G GLASSER AL COUDRAY N CHAPLAIN G GUERRIN J

Citation: S. Lizardnacol et al., LOSS OF HETEROZYGOSITY AT THE TP53 GENE - INDEPENDENT OCCURRENCE FROMGENETIC INSTABILITY EVENTS IN NODE-NEGATIVE BREAST-CANCER, International journal of cancer, 72(4), 1997, pp. 599-603

Authors: LIZARD G ROIGNOT P MAYNADIE M LIZARDNACOL S POUPON MF BORDES M

Citation: G. Lizard et al., FLOW-CYTOMETRY EVALUATION OF THE MULTIDRUG-RESISTANT PHENOTYPE WITH FUNCTIONAL TESTS INVOLVING UPTAKE OF DAUNORUBICIN, HOECHST-33342, OR RHODAMINE-123 - A COMPARATIVE-STUDY, Cancer detection and prevention, 19(6), 1995, pp. 527-534

Authors: LIZARDNACOL S LIDEREAU R COLLIN F ARNAL M HAHNEL L ROIGNOT P CUISENIER J GUERRIN J

Citation: S. Lizardnacol et al., BENIGN BREAST DISEASE - ABSENCE OF GENETIC ALTERATIONS AT SEVERAL LOCI IMPLICATED IN BREAST-CANCER MALIGNANCY, Cancer research, 55(19), 1995, pp. 4416-4419

Authors: LIZARD G MAYNADIE M ROIGNOT P LIZARDNACOL S POUPON MF

Citation: G. Lizard et al., EVALUATION OF MULTIDRUG-RESISTANT PHENOTYPE BY NOW CYTOMETRY WITH MONOCLONAL-ANTIBODIES AND FUNCTIONAL TESTS, Bulletin du cancer, 82(3), 1995, pp. 211-217

Authors: LIZARDNACOL S ARNOULD L RIEDINGER JM ARNAL M COLLIN F GUERRIN J

Citation: S. Lizardnacol et al., AMPLIFICATION OF C-MYC AND C-ERB-BETA-2 ( HER-2 NEU) IN BREAST-CANCERWITHOUT LYMPH-NODE INVOLVEMENT - CORRELATION WITH OTHER PROGNOSTIC PARAMETERS/, Bulletin du cancer, 81(9), 1994, pp. 780-784